The pharma giant AstraZeneca has requested that the European authorisation for its Covid-19 vaccine be pulled, according to ...
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to ...
AstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker said Wednesday. The shot ...
The vaccine, initially approved in January 2021, faced safety concerns over rare blood clots, prompting various countries to halt its use temporarily.
In an update on the European Medicines Agency's website Wednesday ... But studies later suggested that the pricier messenger ...
BioNTech's long-term outlook helped it shrug off a first-quarter loss and sinking revenue as demand for COVID-19 vaccines ...
Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...
GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents related to messenger RNA (mRNA) technology in their COVID-19 ...
GSK says it is owed a portion of Pfizer and BioNTech’s Covid-19 vaccine sales in the latest patent suit filed against the Comirnaty partners. In a lawsuit filed in federal ...
GSK (NYSE:GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain mRNA technology for their COVID-19 Comirnaty vaccines. GSK, also known ...